Comparison 1. Induction versus no induction.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Mortality	3	140	Risk Ratio (M‐H, Random, 95% CI)	0.93 [0.67, 1.27]
2 Acute rejection grade II or higher	3	140	Risk Ratio (M‐H, Random, 95% CI)	0.68 [0.33, 1.41]
3 Adverse events	1		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected
4 Infection	2	104	Risk Ratio (M‐H, Random, 95% CI)	1.40 [0.97, 2.01]
5 Pneumonia	2	96	Risk Ratio (M‐H, Random, 95% CI)	1.38 [0.18, 10.63]
6 CMV infection	2	80	Risk Ratio (M‐H, Random, 95% CI)	1.14 [0.73, 1.80]
7 Bronchiolitis obliterans syndrome	3	140	Risk Ratio (M‐H, Random, 95% CI)	0.74 [0.51, 1.07]
8 Post‐transplantation lymphoproliferative disease (PTLD)	1		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected
9 Cancer	1		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected